Abbott Laboratories
ABT
$113.61
-$0.51-0.45%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.79% | 2.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.79% | 2.04% | |||
| Cost of Revenue | -3.19% | 4.55% | |||
| Gross Profit | 4.00% | 0.10% | |||
| SG&A Expenses | 41.47% | -1.43% | |||
| Depreciation & Amortization | 0.48% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.89% | 2.46% | |||
| Operating Income | -41.18% | 0.32% | |||
| Income Before Tax | 8.17% | 1.40% | |||
| Income Tax Expenses | 8.58% | 44.47% | |||
| Earnings from Continuing Operations | 8.03% | -7.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.03% | -7.59% | |||
| EBIT | -41.18% | 0.32% | |||
| EBITDA | -30.27% | 0.71% | |||
| EPS Basic | 6.27% | -7.52% | |||
| Normalized Basic EPS | 11.38% | 1.48% | |||
| EPS Diluted | 6.69% | -6.93% | |||
| Normalized Diluted EPS | 11.84% | 1.49% | |||
| Average Basic Shares Outstanding | 0.28% | -0.07% | |||
| Average Diluted Shares Outstanding | -0.13% | -0.08% | |||
| Dividend Per Share | 6.78% | 0.00% | |||
| Payout Ratio | -0.08% | 0.08% | |||